Brodszky, V., Baji, P., Balogh, O., & Péntek, M. (2014). Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries. Springer Berlin Heidelberg.
Citação norma ChicagoBrodszky, Valentin, Petra Baji, Orsolya Balogh, and Márta Péntek. Budget Impact Analysis of Biosimilar Infliximab (CT-P13) for the Treatment of Rheumatoid Arthritis in Six Central and Eastern European Countries. Springer Berlin Heidelberg, 2014.
Citação norma MLABrodszky, Valentin, Petra Baji, Orsolya Balogh, and Márta Péntek. Budget Impact Analysis of Biosimilar Infliximab (CT-P13) for the Treatment of Rheumatoid Arthritis in Six Central and Eastern European Countries. Springer Berlin Heidelberg, 2014.